Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

205
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
205
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

189
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
189
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

201
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
201
Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

567
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
567
Group Therapy01:26

Group Therapy

450
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
450

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Clinical Datasets in Practice: Applications for Learners, Clinician-Educators, and Health Services Teams.

Clinical and translational science·2026
Same author

Antioxidant Therapy Reverses Hepatotoxicity Induced by Microcystin-LR in a Cellular Model of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Journal of xenobiotics·2026
Same author

Exploring the Mechanism of Na<sup>+</sup>/K<sup>+</sup>-ATPase (NKA) and 20-HETE Ligand Interactions by in-silico modeling.

bioRxiv : the preprint server for biology·2026
Same author

Obesity is associated with distinct oxylipins in heart failure with preserved ejection fraction.

Metabolomics : Official journal of the Metabolomic Society·2026
Same author

The future is now: How AI is reshaping spine care.

North American Spine Society journal·2025
Same author

Re: "Intellectual conflicts of interest in spinal cord stimulation research - The gap between theoretical knowledge and clinical expertise".

Interventional pain medicine·2025

Related Experiment Video

Updated: Feb 8, 2026

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

3.9K

Pharmaceutical therapy for radiculopathy.

Christopher J Visco1, David S Cheng, David J Kennedy

  • 1Department of Rehabilitation and Regenerative Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. cv2245@columbia.edu

Physical Medicine and Rehabilitation Clinics of North America
|February 5, 2011
PubMed
Summary
This summary is machine-generated.

This review covers pharmaceutical treatments for radiculopathy, including opioids, anti-inflammatories, and neuromodulators. It examines their history, literature, and current applications on the neural axis.

More Related Videos

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.7K
Coherent anti-Stokes Raman Scattering CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution
09:59

Coherent anti-Stokes Raman Scattering CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution

Published on: July 4, 2014

18.6K

Related Experiment Videos

Last Updated: Feb 8, 2026

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

3.9K
Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.7K
Coherent anti-Stokes Raman Scattering CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution
09:59

Coherent anti-Stokes Raman Scattering CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution

Published on: July 4, 2014

18.6K

Area of Science:

  • Pharmacology
  • Neurology
  • Pain Management

Background:

  • Radiculopathy involves nerve root compression, causing pain and neurological deficits.
  • Pharmaceutical interventions are a cornerstone of radiculopathy management.
  • Understanding medication mechanisms and applications is crucial for effective treatment.

Purpose of the Study:

  • To provide a comprehensive review of pharmaceutical treatments for radiculopathy.
  • To explore the historical context and evolution of medication use in radiculopathy.
  • To summarize current treatment options, their indications, and the supporting literature.

Main Methods:

  • Literature review of pharmaceutical agents used for radiculopathy.
  • Analysis of medication classes including opioids, anti-inflammatories, and neuromodulators.
  • Examination of treatment mechanisms acting locally, peripherally, or centrally.

Main Results:

  • Identified various pharmaceutical classes used for radiculopathy.
  • Detailed the historical progression of these treatments.
  • Outlined current therapeutic strategies and their indications.

Conclusions:

  • Pharmaceuticals offer diverse treatment modalities for radiculopathy.
  • A thorough understanding of available literature guides optimal medication selection.
  • Current treatments target the neural axis through various mechanisms for symptom relief.